Respiratory syncytial virus is one of the leading causes of death for infants globally, and a safe vaccine has yet to be approved for use. However, the long search may soon be over, as new structure-based vaccine technology holds great promise.
Respiratory syncytial virus is one of the leading causes of death for infants globally, and a safe vaccine has yet to be approved for use. However, the long search may soon be over, as new structure-based vaccine technology holds great promise.